Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Faysal Haroun

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
BMJ Case Reports|July 2, 2020
Filgrastim induced thrombocytopeniaGhazal Kango, Faysal Haroun
Anticancer Research|May 29, 2017
Erdheim-Chester Disease: Comprehensive Review of Molecular Profiling and Therapeutic AdvancesFaysal Haroun, Kristen Millado, Imad Tabbara
American Journal of Clinical Oncology|December 18, 2018
Novel Immunotherapeutic Agents for the Treatment of Multiple MyelomaHind Rafei, Faysal Haroun, Imad A Tabbara
BMJ Case Reports|August 12, 2017
Extramedullary haematopoiesis presenting with cardiac tamponade in a patient with polycythaemia veraFaysal Haroun, Viktoria Elkis, Anne Chen, et al.
BMJ Case Reports|October 15, 2016
Anaemia with inflammation responding to lenalidomideFaysal Haroun, Andrew Mener, Jacob Elkon, et al.
BMJ Case Reports|March 11, 2019
An atypical presentation of Sweet's syndrome in a myelofibrosis patientUmera Thebo, Sirisha Tummala, Samah Nassereddine, et al.
BMJ Case Reports|October 11, 2018
Two distinct histological Richter's transformations 23 years apart in a patient with chronic lymphocytic leukaemiaUmera Thebo, Ralph Linwood Millett, Jacob Elkon, et al.
Annals of Hematology|June 24, 2017
PD-1 signaling and inhibition in AML and MDSFaysal Haroun, Sade A Solola, Samah Nassereddine, et al.
Annals of Hematology|November 2, 2017
The role of mutant IDH1 and IDH2 inhibitors in the treatment of acute myeloid leukemiaSamah Nassereddine, Coen J Lap, Faysal Haroun, et al.
Cancers|February 11, 2023
Integrating Immunotherapy into Multimodal Treatment of Head and Neck CancerYuan James Rao, Joseph F Goodman, Faysal Haroun, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
BMJ Case Reports|July 2, 2020
Filgrastim induced thrombocytopeniaGhazal Kango, Faysal Haroun
Anticancer Research|May 29, 2017
Erdheim-Chester Disease: Comprehensive Review of Molecular Profiling and Therapeutic AdvancesFaysal Haroun, Kristen Millado, Imad Tabbara
American Journal of Clinical Oncology|December 18, 2018
Novel Immunotherapeutic Agents for the Treatment of Multiple MyelomaHind Rafei, Faysal Haroun, Imad A Tabbara
BMJ Case Reports|August 12, 2017
Extramedullary haematopoiesis presenting with cardiac tamponade in a patient with polycythaemia veraFaysal Haroun, Viktoria Elkis, Anne Chen, et al.
BMJ Case Reports|October 15, 2016
Anaemia with inflammation responding to lenalidomideFaysal Haroun, Andrew Mener, Jacob Elkon, et al.
BMJ Case Reports|March 11, 2019
An atypical presentation of Sweet's syndrome in a myelofibrosis patientUmera Thebo, Sirisha Tummala, Samah Nassereddine, et al.
BMJ Case Reports|October 11, 2018
Two distinct histological Richter's transformations 23 years apart in a patient with chronic lymphocytic leukaemiaUmera Thebo, Ralph Linwood Millett, Jacob Elkon, et al.
Annals of Hematology|June 24, 2017
PD-1 signaling and inhibition in AML and MDSFaysal Haroun, Sade A Solola, Samah Nassereddine, et al.
Annals of Hematology|November 2, 2017
The role of mutant IDH1 and IDH2 inhibitors in the treatment of acute myeloid leukemiaSamah Nassereddine, Coen J Lap, Faysal Haroun, et al.
Cancers|February 11, 2023
Integrating Immunotherapy into Multimodal Treatment of Head and Neck CancerYuan James Rao, Joseph F Goodman, Faysal Haroun, et al.
Pageof 2